All stock lists
Macerich Co (New York Stock Exchange:MAC)
US · Delayed Price · Currency is USD
24.10+0.15 (+0.63%)
Insider Score
––Not scored
MAC Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MAC analyst forecast
MAC analyst consensus
No analyst ratings in the last 3 months.
MAC 12-month price target
$25.33+3.7% upsideaverage of 6 firms
$28.00High
$22.00Low
Best analysts covering MAC
No firm covering MAC has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MAC analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Piper Sandler | — | $26.00 | +16.9% | — | 2026-10-12 | |
| BNP Paribas | — | $28.00 | +26.1% | — | 2026-10-09 | |
| Piper Sandler | — | $30.00 | +24.1% | — | 2026-08-27 | |
| Griffin | — | $26.00 | +5.4% | — | 2026-08-18 | |
| Piper Sandler | — | $28.00 | +9.4% | — | 2026-07-21 | |
| Truist Financial | — | $26.00 | +6.6% | — | 2026-06-23 | |
| Scotiabank | — | $24.00 | +10.0% | — | 2026-05-19 | |
| Evercore ISI | — | $22.00 | +1.5% | — | 2026-05-08 | |
| Scotiabank | — | $16.00 | +11.3% | — | 2025-04-23 | |
| Truist Financial | — | $19.00 | +11.4% | — | 2025-04-01 | |
| Jefferies | — | $23.00 | +15.5% | — | 2025-01-01 | |
| Piper Sandler | — | $17.00 | -20.4% | — | 2024-12-11 | |
| Piper Sandler | — | $14.00 | -8.9% | — | 2024-09-03 | |
| Scotiabank | — | $14.00 | -12.9% | — | 2024-05-17 | |
| Piper Sandler | — | $11.00 | -20.1% | — | 2024-05-01 | |
| Jefferies | — | $19.00 | +10.7% | — | 2021-07-15 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
